Therapy of pruritus

Bibliography

• Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994;56:36-40
   PubMed Web of Science ®Google Scholar
• Haffenrefer S. Nosodochium in quo cutis, eique adherentium partium, affecta omnes singulari methodo et cognoscendi et curandi fidelissime tradutus. In: Ulm K, editor, De pruritu; 1660. p. 98-102
   Google Scholar
• Yosipovitch G, Greaves M. Defintions of itch. In: Yosipovitch G, Greaves MW, Fleischer AB Jr, McGlone F, editors, Itch: basic mechanisms and therapy. Marcel Dekker, New York; 2004. p. 1-4
   Google Scholar
• Pisoni RL, Wikstrom B, Elder SJ, Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006;21:3495-505
   PubMed Web of Science ®Google Scholar
• Kretzmer GE, Gelkopf M, Kretzmer G, Melamed Y. Idiopathic pruritus in psychiatric inpatients: an explorative study. Gen Hosp Psychiatry 2008;30:344-8
   PubMed Web of Science ®Google Scholar
• Stander S, Weisshaar E, Mettang T, Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007;87:291-4
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Goon A, Wee J, The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000;143:969-73
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Ansari N, Goon A, Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol 2002;147:32-6
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Goon AT, Wee J, Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol 2002;41:212-16
   PubMed Web of Science ®Google Scholar
• Narita I, Alchi B, Omori K, Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 2006;69:1626-32
   PubMed Web of Science ®Google Scholar
• Duque MI, Vogel CA, Fleischer AB Jr, Yosipovitch G. Over-the-counter topical antipruritic agents are commonly recommended by office-based physicians: an analysis of US practice patterns. J Dermatolog Treat 2004;15:185-8
   PubMedGoogle Scholar
• Lee CH, Chuang HY, Shih CC, epidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. Br J Dermatol 2006;154:1100-7
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Xiong GL, Haus E, Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature. J Invest Dermatol 1998;110:20-3
   PubMed Web of Science ®Google Scholar
• Patel T, Ishiuji Y, Yosipovitch G. Nocturnal itch: why do we itch at night? Acta Derm Venereol 2007;87:295-8
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Neisius U, Ikoma A, Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003;23:6176-80
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep 2008;8:306-11
   PubMed Web of Science ®Google Scholar
• Zhai H, Frisch S, Pelosi A, Antipruritic and thermal sensation effects of hydrocortisone creams in human skin. Skin Pharmacol Appl Skin Physiol 2000;13:352-7
   PubMedGoogle Scholar
• Hon KL, Lam MC, Leung TF, Assessing itch in children with atopic dermatitis treated with tacrolimus: objective versus subjective assessment. Adv Ther 2007;24:23-8
   PubMed Web of Science ®Google Scholar
• Kaufmann R, Bieber T, Helgesen AL, Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. Allergy 2006;61:375-81
   PubMed Web of Science ®Google Scholar
• Stander S, Schurmeyer-Horst F, Luger TA, Weisshaar E. Treatment of pruritic diseases with topical calcineurin inhibitors. Ther Clin Risk Manag 2006;2:213-18
   PubMedGoogle Scholar
• Pereira U, Boulais N, Lebonvallet N, Mechanisms of sensory effects of tacrolimus on the skin. Br J Dermatol 2010. [Epub ahead of print]
   Web of Science ®Google Scholar
• Senba E, Katanosaka K, Yajima H, Mizumura K. The immunosuppressant FK506 activates capsaicin- and bradykinin-sensitive DRG neurons and cutaneous C-fibers. Neurosci Res 2004;50:257-62
   PubMed Web of Science ®Google Scholar
• Stander S, Stander H, Seeliger S, Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol 2007;156:1020-6
   PubMed Web of Science ®Google Scholar
• Shim WS, Tak MH, Lee MH, TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 2007;27:2331-7
   PubMed Web of Science ®Google Scholar
• Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxn cream. The Doxepin Study Group. J Am Acad Dermatol 1994;31:613-16
   PubMed Web of Science ®Google Scholar
• Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol 1995;131:1403-8
   PubMedGoogle Scholar
• McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002;416:52-8
   PubMed Web of Science ®Google Scholar
• Peier AM, Moqrich A, Hergarden AC, A TRP channel that senses cold stimuli and menthol. Cell 2002;108:705-15
   PubMed Web of Science ®Google Scholar
• Bromm B, Scharein E, Darsow U, Ring J. Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett 1995;187:157-60
   PubMed Web of Science ®Google Scholar
• Patel T, Ishiuji Y, Yosipovitch G. Menthol: a refreshing look at this ancient compound. J Am Acad Dermatol 2007;57:873-8
   PubMed Web of Science ®Google Scholar
• Caterina MJ, Schumacher MA, Tominaga M, The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389:816-24
   PubMed Web of Science ®Google Scholar
• Jessell TM, Iversen LL, Cuello AC. Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res 1978;152:183-8
   PubMed Web of Science ®Google Scholar
• Imamachi N, Park GH, Lee H, TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci USA 2009;106:11330-5
   PubMed Web of Science ®Google Scholar
• Stander S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001;44:471-8
   PubMed Web of Science ®Google Scholar
• Leibsohn E. Treatment of notalgia paresthetica with capsaicin. Cutis 1992;49:335-6
   PubMed Web of Science ®Google Scholar
• Breneman DL, Cardone JS, Blumsack RF, Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 1992;26:91-4
   PubMed Web of Science ®Google Scholar
• Goodless DR, Eaglstein WH. Brachioradial pruritus: treatment with topical capsaicin. J Am Acad Dermatol 1993;29:783-4
   PubMed Web of Science ®Google Scholar
• Lotti T, Teofoli P, Tsampau D. Treatment of aquagenic pruritus with topical capsaicin cream. J Am Acad Dermatol 1994;30:232-5
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Maibach HI, Rowbotham MC. Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia. Acta Derm Venereol 1999;79:118-21
   PubMed Web of Science ®Google Scholar
• Wang H, Papoiu AD, Coghill RC, Ethnic differences in pain, itch and thermal detection in response to topical capsaicin: African Americans display a notably limited hyperalgesia and neurogenic inflammation. Br J Dermatol 2009. [Epub ahead of print]
   Google Scholar
• Yosipovitch G, Maibach HI. Effect of topical pramoxine on experimentally induced pruritus in humans. J Am Acad Dermatol 1997;37:278-80
   PubMed Web of Science ®Google Scholar
• Shuttleworth D, Hill S, Marks R, Connelly DM. Relief of experimentally induced pruritus with a novel eutectic mixture of local anaesthetic agents. Br J Dermatol 1988;119:535-40
   PubMed Web of Science ®Google Scholar
• Sandroni P. Central neuropathic itch: a new treatment option? Neurology 2002;59:778-9
   PubMed Web of Science ®Google Scholar
• Young TA, Patel TS, Camacho F, A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients. J Dermatolog Treat 2009;20:76-81
   PubMed Web of Science ®Google Scholar
• Villamil AG, Bandi JC, Galdame OA, Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases. Am J Med 2005;118:1160-3
   PubMed Web of Science ®Google Scholar
• Freitag G, Hoppner T. Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. Curr Med Res Opin 1997;13:529-37
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Sugeng MW, Chan YH, The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol 2001;45:910-13
   PubMed Web of Science ®Google Scholar
• Andoh T, Nishikawa Y, Yamaguchi-Miyamoto T, Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice. J Invest Dermatol 2007;127:2042-7
   PubMed Web of Science ®Google Scholar
• Stander S, Schmelz M, Metze D, Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci 2005;38:177-88
   PubMed Web of Science ®Google Scholar
• Dvorak M, Watkinson A, McGlone F, Rukwied R. Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res 2003;52:238-45
   PubMed Web of Science ®Google Scholar
• Szepietowski JC, Szepietowski T, Reich A. Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study. Acta Dermatovenerol Croat 2005;13:97-103
   PubMedGoogle Scholar
• Eberlein B, Eicke C, Reinhardt HW, Ring J. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol 2008;22:73-82
   PubMed Web of Science ®Google Scholar
• Stander S, Reinhardt HW, Luger TA. Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus. Hautarzt 2006;57:801-7
   PubMed Web of Science ®Google Scholar
• Davis MP, Frandsen JL, Walsh D, Mirtazapine for pruritus. J Pain Symptom Manage 2003;25:288-91
   PubMed Web of Science ®Google Scholar
• Hundley JL, Yosipovitch G. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. J Am Acad Dermatol 2004;50:889-91
   PubMed Web of Science ®Google Scholar
• Demierre MF, Taverna J. Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma. J Am Acad Dermatol 2006;55:543-4
   PubMed Web of Science ®Google Scholar
• de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol 1995;10(Suppl 4):19-23
   PubMedGoogle Scholar
• Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy 1997;17:10-21
   PubMed Web of Science ®Google Scholar
• Stander S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol 2008;17:161-9
   PubMed Web of Science ®Google Scholar
• Stander S, Bockenholt B, Schurmeyer-Horst F, Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. Acta Derm Venereol 2009;89:45-51
   PubMed Web of Science ®Google Scholar
• Mayo MJ, Handem I, Saldana S, Sertraline as a first-line treatment for cholestatic pruritus. Hepatology 2007;45:666-74
   PubMed Web of Science ®Google Scholar
• Umeuchi H, Togashi Y, Honda T, Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol 2003;477:29-35
   PubMed Web of Science ®Google Scholar
• Togashi Y, Umeuchi H, Okano K, Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol 2002;435:259-64
   PubMed Web of Science ®Google Scholar
• Pan ZZ. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 1998;19:94-8
   PubMed Web of Science ®Google Scholar
• Kjellberg F, Tramer MR. Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 2001;18:346-57
   PubMed Web of Science ®Google Scholar
• Mansour-Ghanaei F, Taheri A, Froutan H, Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006;12:1125-8
   PubMed Web of Science ®Google Scholar
• Malekzad F, Arbabi M, Mohtasham N, Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. J Eur Acad Dermatol Venereol 2009;23:948-50
   PubMed Web of Science ®Google Scholar
• Jung SI, Seo CH, Jang K, Efficacy of naltrexone in the treatment of chronic refractory itching in burn patients: preliminary report of an open trial. J Burn Care Res 2009;30:257-60
   PubMedGoogle Scholar
• Peer G, Kivity S, Agami O, Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996;348:1552-4
   PubMed Web of Science ®Google Scholar
• Bergasa NV, Alling DW, Talbot TL, Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 1999;41:431-4
   PubMed Web of Science ®Google Scholar
• Monroe EW. Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis. J Am Acad Dermatol 1989;21:135-6
   PubMed Web of Science ®Google Scholar
• Dawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 2006;54:527-31
   PubMed Web of Science ®Google Scholar
• Kumagai H, Ebata T, Takamori K, Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 2010;25(4):1251-7
   Google Scholar
• Kanitakis J. Brachioradial pruritus: report of a new case responding to gabapentin. Eur J Dermatol 2006;16:311-12
   PubMed Web of Science ®Google Scholar
• Loosemore MP, Bordeaux JS, Bernhard JD. Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy. J Eur Acad Dermatol Venereol 2007;21:1440-1
   PubMed Web of Science ®Google Scholar
• Gunal AI, Ozalp G, Yoldas TK, Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 2004;19:3137-9
   PubMed Web of Science ®Google Scholar
• Manenti L, Vaglio A. Gabapentin for uraemic pruritus. Nephrol Dial Transplant 2005;20:1278-9
   PubMed Web of Science ®Google Scholar
• Bergasa NV, McGee M, Ginsburg IH, Engler D. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology 2006;44:1317-23
   PubMed Web of Science ®Google Scholar
• Ehrchen J, Stander S. Pregabalin in the treatment of chronic pruritus. J Am Acad Dermatol 2008;58:S36-S37
   PubMed Web of Science ®Google Scholar
• Duval A, Dubertret L. Aprepitant as an antipruritic agent? N Engl J Med 2009;361:1415-6
   PubMed Web of Science ®Google Scholar
• Wahlgren CF. Itch and atopic dermatitis: clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 1991;165:1-53
   PubMedGoogle Scholar
• Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 2006;367:839-46
   PubMed Web of Science ®Google Scholar
• Meggitt SJ, Reynolds NJ. Azathioprine for atopic dermatitis. Clin Exp Dermatol 2001;26:369-75
   PubMed Web of Science ®Google Scholar
• Bigliardi PL, Stammer H, Jost G, Treatment of pruritus with topically applied opiate receptor antagonist. J Am Acad Dermatol 2007;56:979-88
   PubMed Web of Science ®Google Scholar
• Friedman JD, Dello Buono FA. Opioid antagonists in the treatment of opioid-induced constipation and pruritus. Ann Pharmacother 2001;35:85-91
   PubMed Web of Science ®Google Scholar
• Noto C, Pappagallo M, Szallasi A. NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain. Curr Opin Investig Drugs 2009;10:702-10
   PubMed Web of Science ®Google Scholar
• Arai I, Takano N, Hashimoto Y, Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 2004;505:229-35
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Arai I, Futaki N, Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D2, a mediator that inhibits itching. Prostaglandins Leukot Essent Fatty Acids 2007;76:93-101
   PubMed Web of Science ®Google Scholar
• Arai I, Takaoka A, Hashimoto Y, Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice. Eur J Pharmacol 2007;556:207-14
   PubMedGoogle Scholar
• Sonkoly E, Muller A, Lauerma AI, IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006;117:411-17
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Muller A, Lauerma AI, IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006;117:411-7
   PubMed Web of Science ®Google Scholar
• Grimstad O, Sawanobori Y, Vestergaard C, Anti-interleukin- 31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 2009;18:35-43
   PubMed Web of Science ®Google Scholar
• Dalgard F, Svensson A, Holm JO, Sundby J. Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey. J Investig Dermatol Symp Proc 2004;9:120-5
   PubMedGoogle Scholar
• Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 2010;49:1-11
   PubMed Web of Science ®Google Scholar
• Ikoma A, Steinhoff M, Stander S, The neurobiology of itch. Nat Rev Neurosci 2006;7:535-47
   PubMed Web of Science ®Google Scholar
• Ishiuji Y, Coghill RC, Patel TS, Repetitive scratching and noxious heat do not inhibit histamine-induced itch in atopic dermatitis. Br J Dermatol 2008;158:78-83
   PubMed Web of Science ®Google Scholar